Shenzhen Hepalink (ęµ·ēę®) A+H: Hot Deal that Might Not Fly
Shenzhen Hepalink, a leading heparin manufacturer in China, launched book building to raise up to USD 585 million to list in Hong Kong. In our...
545 Views
Hepalink Pharma IPO: A Step in the Right Direction
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH)Ā is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
424 Views
Hepalink Pharma Triangle Breakout
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) surge off of support does provide better evidence that the triangle pattern will break to the...
470 Views
ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Akeso...
527 Views
Shenzhen Hepalink (ęµ·ēę®) A+H: FY2019 Results Snippet and Valuation Update
Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.In our previous note, we discussed that Shenzhen Hepalink is a dominant...
647 Views